LMRI
Lumexa Imaging Holdings, Inc. Common Stock
Nasdaq · usd
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) trades at $14.10 (-3.62%) as of 5:42:14 AM EST on Nov 19, 2026, +31.18% over the past month. Market cap is $1.35B, with 6.0 days to cover in short interest.
Stock performance
How Lumexa Imaging Holdings, Inc. Common Stock (LMRI) stock has performed from one day to one year, with its 52-week range.
- 1D
- -4.24%
- 1W
- -12.16%
- 1M
- +31.18%
- YTD
- -24.27%
- 1Y
- -24.35%
- 52-wk range
- $6.45 – $19.45
Key statistics
Today's trading snapshot for LMRI: day range, open, previous close, volume and market cap.
- Day range
- $13.90 – $14.84
- Open
- $14.61
- Prev close
- $14.63
- Volume
- 256.56K
- Market cap
- $1.35B
- Shares out
- 96.12M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Lumexa Imaging Holdings, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- 165.46
- P/S
- 1.29
- P/B
- 2.12
- P/FCF
- 34.02
- ROE
- 1.3%
- ROA
- 0.4%
- Debt/Equity
- 1.41
- Div yield
- 0.00%
As of Nov 18, 2026
8-K filings
Material corporate events Lumexa Imaging Holdings, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 10, 2026
On November 10, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing the Company's financial results for the quarter ended September 30, 2026.
- Credit facilityJun 30, 2026
The Amended Credit Agreement provides for (i) a secured term loan facility of approximately $823 million (the 'Replacement Term Loan') and (ii) a secured revolving line of credit of $250 million (the 'Amended Revolving Credit Facility'). The Replacement Term Loan will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50%, and will mature in December 2032. The Amended Revolving Credit Facility will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50% (subject to reduction upon the achievement of certain senior secured net leverage ratios), and will mature in December 2030.
- Annual meeting resultsJun 12, 2026
At the Annual Meeting, all three director nominees were elected and the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified. Set forth below are the final voting results for the proposals submitted to a vote of the Company's stockholders at the Annual Meeting.
- Guidance issuance or updateApr 9, 2026
On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.
- Preliminary resultsMar 26, 2026
On March 26, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing certain preliminary financial information for the quarter and year ended December 31, 2025. The preliminary financial information set forth in the press release for the quarter and year ended December 31, 2025 reflects preliminary, unaudited estimates with respect to such results based solely on currently available information, which is subject to change.
LMRI short interest
How heavily LMRI is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 6.0
- Short interest
- 1.81M
- Avg volume
- 301.31K
As of · reported to FINRA twice monthly.
LMRI news
The latest news and headlines about Lumexa Imaging Holdings, Inc. Common Stock (LMRI).
- Why Lumexa (LMRI) Might be Well Poised for a SurgepositiveZacks Investment Research· Nov 17, 2026
- Lumexa Imaging Opens Three New Imaging Centers in NovemberpositiveGlobeNewswire Inc.· Nov 16, 2026
- Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint VenturepositiveGlobeNewswire Inc.· Nov 12, 2026
- Lumexa Imaging Announces Participation in Upcoming Investor ConferencesneutralGlobeNewswire Inc.· Aug 25, 2026
- Lumexa Imaging Appoints Kyle Lynch as Chief Growth OfficerpositiveGlobeNewswire Inc.· Apr 20, 2026
Frequently asked questions
What is the Lumexa Imaging Holdings, Inc. Common Stock (LMRI) stock price today?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is trading at $14.10 (-3.62% on the day) as of 5:42:14 AM EST on Nov 19, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Lumexa Imaging Holdings, Inc. Common Stock?
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography.
What is the short interest in LMRI?
As of Oct 30, 2026, LMRI has 1.81M shares short and 6.0 days to cover.
What exchange is LMRI listed on?
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) trades on Nasdaq in USD, in the SERVICES-MEDICAL LABORATORIES industry.
Build with AI
Build an analysis of LMRI with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LMRI analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.